C. Marchetti, G. Scambia, D. Giannarelli, G. Vizzielli, M. G. Ferrandina, L. Tortorella, F. Fanfani, B. Costantini, T. Pasciuto, A. Fagotti
{"title":"原发性减瘤手术后晚期卵巢癌患者与新辅助化疗后的生活质量:来自随机SCORPION试验的结果","authors":"C. Marchetti, G. Scambia, D. Giannarelli, G. Vizzielli, M. G. Ferrandina, L. Tortorella, F. Fanfani, B. Costantini, T. Pasciuto, A. Fagotti","doi":"10.1136/ijgc-2022-esgo.849","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":367178,"journal":{"name":"Quality of life after treatment","volume":"43 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"2022-RA-972-ESGO Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: results from the randomized SCORPION Trial\",\"authors\":\"C. Marchetti, G. Scambia, D. Giannarelli, G. Vizzielli, M. G. Ferrandina, L. Tortorella, F. Fanfani, B. Costantini, T. Pasciuto, A. Fagotti\",\"doi\":\"10.1136/ijgc-2022-esgo.849\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":367178,\"journal\":{\"name\":\"Quality of life after treatment\",\"volume\":\"43 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Quality of life after treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ijgc-2022-esgo.849\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Quality of life after treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2022-esgo.849","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
2022-RA-972-ESGO Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: results from the randomized SCORPION Trial